ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 238 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $290,777 | -100.0% | 12,141 | -73.7% | 0.00% | -60.0% |
| Q2 2022 | $651,011,000 | -60.3% | 46,171 | -31.7% | 0.01% | -50.0% |
| Q1 2022 | $1,638,289,000 | -14.5% | 67,642 | -17.6% | 0.01% | -9.1% |
| Q4 2021 | $1,916,615,000 | +27.0% | 82,082 | -9.6% | 0.01% | +10.0% |
| Q3 2021 | $1,508,852,000 | -33.5% | 90,840 | -2.3% | 0.01% | -33.3% |
| Q2 2021 | $2,267,270,000 | -5.0% | 92,959 | +0.5% | 0.02% | -11.8% |
| Q1 2021 | $2,385,881,000 | -19.0% | 92,476 | +67.8% | 0.02% | -34.6% |
| Q4 2020 | $2,945,539,000 | +216.8% | 55,098 | +144.4% | 0.03% | +160.0% |
| Q3 2020 | $929,858,000 | – | 22,542 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |